Home Investing in the future of diagnostics

Latest news

This image is a promotional graphic for the MEDICA event. It shows the event's logo on the left and provides the key details on the right: the location is Düsseldorf, Germany, and the dates are November 17-20, 2025.
2025-11 / MEDICA 2025
The image shows a person dressed in a white medical coat, likely a doctor or healthcare professional, interacting with a futuristic, digital interface. The interface prominently displays the letters "AI" in the center, surrounded by various holographic graphics, charts, and icons related to health and technology. The person is pointing at the interface with their finger, as if engaging with the digital data. The background appears to be a modern hospital or medical facility, with medical equipment visible in the room.
AI in ANA Testing: A New Era in Autoimmune Diagnostics
Das Bild zeigt einen großen Konferenzraum, in dem zahlreiche Zuhörer einer Präsentation beiwohnen. Vorne befinden sich zwei Bildschirme, auf denen Folien gezeigt werden, ein Redner steht auf einem Podium und eine weitere Person sitzt neben ihm. Der Raum ist gut beleuchtet, durch die Fenster fällt etwas Tageslicht herein, und in der Nähe der Bühne stehen Blumenarrangements.
From Biomarkers to AI: Highlights of the 17th Dresden Symposium on Autoantibodies 2025
The picture shows a woman looking into a microscope. On the left side, there's a graphic of a test strip with multiple wells. Two arrows point to microscopic images showing the results of two different fixation methods: one for ethanol-fixed samples and one for formalin-fixed samples. The microscopic images show a green fluorescent pattern, which is characteristic of ANCA (anti-neutrophil cytoplasmic antibodies) testing.
ANCA dual: Two Targets, One Powerful Diagnostic Tool for ANCA-Associated Vasculitis
This image is a save-the-date announcement for the "17th Dresden Symposium on Autoantibodies," scheduled for September 9-12, 2025. It features a panoramic photo of the city of Dresden, Germany, with the Elbe river in the foreground and the historic skyline in the background. The website www.gfid-ev.de is also included.
2025-09 / Medipan & GA Generic Assays at 17. Dresdner Symposium on Autoantibodies (DSA)
Dies ist eine Grafik, die ein von der EU gefördertes Projekt von der GA Generic Assays GmbH darstellt. Das Bild zeigt eine Frau in einem Labor, die eine VR-Brille trägt und mit holografischen Bildschirmen interagiert. Der Text auf dem Bild lautet: "EUROPA FÖRDERT BRANDENBURG", "INVESTITIONEN IN INNOVATION, WACHSTUM UND ENTWICKLUNG" und weitere Details. Es visualisiert eine Verbindung zwischen wissenschaftlicher Innovation und EU-Förderung.
13.05.2024

Investing in the future of diagnostics

GA Generic Assays receives funding from the Just Transition Fund (JTF)

We are very pleased that GA Generic Assays has received funding from the Just Transition Fund (JTF) for the expansion of our existing facility. The aim of this project is to expand our production of immunological test kits for the serological diagnosis of autoimmune diseases.

The Ministry of Economic Affairs, Labour, Energy and Climate Protection of the State of Brandenburg (MWAEK) funds the project as part of the EU 2021–2027 funding period. The Investitionsbank des Landes Brandenburg (ILB) is supporting the program as the central point of contact.

Our project focuses on the acquisition of modern laboratory and production technology, including:

  1. Pipetting and coating robots
  2. Fume cupboards with air drying
  3. Label butter

These investments allow us to expand production and maintain the highest quality standards in diagnostic products.

As an innovative technology company, we cooperate closely with industry and science and maintain strong networks at home and abroad. We promote our competitiveness and contribute to the sustainable economic development of the Lusatia region.

About the JTF program

The Just Transition Fund supports companies in navigating the social, economic, and ecological challenges of structural change. In particular, the program promotes targeted investments that actively address the transition away from coal and foster sustainable growth.

We sincerely thank the State of Brandenburg, the MWAEK, and the ILB for their trust and support. Their commitment allows us to strengthen our innovation capacity, expand our production capabilities, and continue advancing diagnostic solutions for autoimmune diseases, benefiting both patients and the broader community.